Attenuated metabolic effect of waist measurement in Japanese female patients with type 2 diabetes mellitus

Diabetes Research and Clinical Practice

Volumn 82, Issue 1, 2008, Pages 66-72

  Tajiri, Yuji ^a,b   Takei, Ryoko ^b   Mimura, Kazuo ^b   Umeda, Fumio ^b  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Fukuoka Medical Association Hospital   (Japan)

Author keywords

Cardiovascular disease; Risk factors; Type 2 diabetes mellitus; Waist circumference

Indexed keywords

C PEPTIDE; C REACTIVE PROTEIN; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DISEASE COURSE; DISEASE DURATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; JAPANESE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK FACTOR; SEX DIFFERENCE; WAIST CIRCUMFERENCE;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD PRESSURE; C-PEPTIDE; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; TRIGLYCERIDES; WAIST CIRCUMFERENCE;

EID: 52949135160     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2008.05.015     Document Type: Article

References (27)

1. Despres J.P., Lamarche B., Mauriege P., Cantin B., Dagenais G.R., Moorjani S., et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N. Engl. J. Med. 334 (1996) 952-957
2. World Health Organization, Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation. Geneva, World Health Organization, 1999.
3. Balkau B., and Charles M.A. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diab. Med. 16 (1999) 442-443
4. Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults, Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III), JAMA 285 (2001) 2486-2497.
5. Alberti K.G.M.M., Zimmet P., and Shaw J. Metabolic syndrome-a new world-wide definition. A consensus statement from the International Diabetes Federation. Diab. Med. 23 (2006) 469-480
6. Japan Society for the Study of Obesity. The examination committee of criteria for 'Obesity Disease' in Japan. Circ. J. 66 (2002) 987-992
7. Sone H., et al. The new worldwide definition of metabolic syndrome is not a better diagnostic predictor of cardiovascular disease in Japanese diabetic patients than the existing definitions. Diabetes Care 29 (2006) 145-147
8. Wajchenberg B.L. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocrinol. Rev. 21 (2000) 697-738
9. Tajiri Y., Mimura K., and Umeda F. High-sensitivity C-reactive protein in Japanese patients with type 2 diabetes. Obesity Res. 13 (2005) 1810-1816
10. Kuzuya T., Nakagawa S., Satoh J., Kanazawa Y., Iwamoto Y., Kobayashi M., et al. Committee of the Japan Diabetes Society on the diagnostic criteria of diabetes mellitus, report of the committee on the classification and diagnostic criteria of diabetes mellitus. Diab. Res. Clin. Pract. 55 (2002) 65-85
11. Definition and the diagnostic standard for metabolic syndrome-Committee to evaluate diagnostic standards for metabolic syndrome. Nippon Naika Gakkai Zasshi 94 (2005) 794-809 (in Japanese)
12. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18 (1972) 499-502
13. Roberts W.L., Sedrick R., Moulton L., Spencer A., and Rifai N. Evaluation of four automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Clin. Chem. 46 (2000) 461-468
14. Hara K., Matsushita Y., Horikoshi M., Yoshiike N., Yokoyama T., Tanaka H., et al. A proposal for the cutoff point of waist circumference for the diagnosis of metabolic syndrome in the Japanese population. Diabetes Care 29 (2006) 1123-1124
15. Miyawaki T., Hirata M., Moriyama K., Sasaki Y., Aono H., Saito N., et al. Metabolic syndrome diagnosed with visceral fat measurement by computed tomography. Proc. Jpn. Acad. (Ser. B) 81 (2005) 471-479
16. Enzi G., Gasparo M., Biondetti P.R., Fiore D., Semisa M., and Zurlo F. Subcutaneous and visceral fat distribution according to sex, age and overweight, evaluated by computed tomography. Am. J. Clin. Nutr. 44 (1986) 739-746
17. Borkan G.A., Hults D.E., Gerzof S.G., Robbins A.H., and Silbert C.K. Age changes in body composition revealed by computed tomography. J. Gerontol. 38 (1983) 673-677
18. Matsuzawa Y., Nakamura T., Shimomura I., and Kotami K. Visceral fat accumulation and cardiovascular disease. In: Angel A., Anderson H., Bouchard C., Lau D., Leiter L., and Mendelson R. (Eds). Progress in Obesity Research: Proceedings of the Seventh International Congress on Obesity, vol. 7. Toronto, Canada, August 20-25, 1994 (1996), John Libbey & Company, London 569-572
19. Zamboni M., Armellini F., Muller D., Sorkin J., Turcato E., Andres R., et al. Methodological and clinical aspects of subcutaneous fat distribution. In: Angel A., Anderson H., Bouchard C., Lau D., Leiter L., and Mendelson R. (Eds). Progress in Obesity Research: Proceedings of the Seventh International Congress on Obesity, vol. 7. Toronto, Canada, August 20-25, 1994 (1996), John Libbey & Company, London 145-150
20. Despres J.P., Nadeau A., Tremblay A., Ferland M., Moorjani S., Lupien P.J., et al. Role of deep abdominal fat in the association between regional adipose tissue distribution and glucose tolerance in obese women. Diabetes 38 (1989) 304-309
21. Pouliot M.C., Despres J.P., Nadeau A., Moorjani S., Prudhomme D., Lupien P.J., et al. Visceral obesity in men. Associations with glucose tolerance, plasma insulin and lipoprotein levels. Diabetes 41 (1992) 826-834
22. Despres J.P., Moorjani S., Lupien P.J., Tremblay A., Nadeau A., and Bouchard C. Regional distribution of body fat, plasma lipoproteins and cardiovascular disease. Arteriosclerosis 10 (1990) 497-511
23. Despres J.P. Obesity and lipid metabolism: relevance of body fat distribution. Curr. Opin. Lipidol. 2 (1991) 5-15
24. Despres J.P. Lipoprotein metabolism in visceral obesity. Int. J. Obes. 15 (1991) 45-52
25. Lemieux S., Despres J.P., Moorjani S., Nadeau A., Theriault G., Prudhomme D., et al. Are gender differences in cardiovascular disease risk factors explained by the level of visceral adipose tissue?. Diabetologia 37 (1994) 757-764
26. Sjostrom L., Lonn L., Chowdhury B., Grangard Lissner L., Sjostrom D., and Sullivan L. The sagittal diameter is a valid marker of the visceral adipose tissue volume. In: Angel A., Anderson H., Bouchard C., Lau D., Leiter L., and Mendelson R. (Eds). Progress in Obesity Research: Proceedings of the Seventh International Congress on Obesity, vol. 7. Toronto, Canada, August 20-25, 1994 (1996), John Libbey & Company, London 309-319
27. Chowdhury B., Sjostrom L., Alpsten M., Kostanty J., Kvist H., and Lofgren R. A multicompartment body composition technique based on computorized tomography. Int. J. Obes. Relat. Metab. Disord. 18 (1994) 219-234